DY

Doron Yannai

Active Director Director DIN 08275300
DIN 08275300 First appointment Nov 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Doron Yannai

Data last updated:

Doron Yannai is a Director at Alma Medical Private Limited (since 2018). The company operates in Healthcare. Alma Medical Private Limited reported revenue of ₹89.64 Cr (FY 2024).

DIN 08275300
Primary Designation Director
Industry Healthcare
First Appointment 15 Nov 2018
Oldest Company Age 11 yrs
Largest company Alma Medical Private Limited · ₹89.64 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alma Medical Private Limited U74120MH2014FTC259931
Director15 Nov 20182014₹89.64 Cr (FY 2024)Active

Board colleagues of Doron Yannai

Directorship timeline

Open interactive timeline →
Alma Medical Private Limited
Premium access

Shareholding and investment profile for Doron Yannai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Doron Yannai

Doron Yannai currently holds 1 directorship: Alma Medical Private Limited (Director, since 15 Nov 2018, revenue ₹89.64 Cr (FY 2024)).

Doron Yannai was first appointed on 15 Nov 2018 as Director at Alma Medical Private Limited.

The current boards of Doron Yannai's companies include Alon Tzionit (Alma Medical Private Limited), Amit Deviprasad Shukla (Alma Medical Private Limited), Rohit Kamal Jain (Alma Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available